Cargando…

Disease characteristics and treatment patterns of Chinese patients with metastatic colorectal cancer: a retrospective study using medical records from China

BACKGROUND: Colorectal cancer (CRC) is the third most prevalent cancer in China but few large-scale studies were conducted to understand CRC patients. The current study is aimed to gain a real-world perspectives of CRC patients in China. METHODS: Using electronic medical records of sampled patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Ruihua, Wang, Wei, Zhu, Bo, Lin, Xiaoyan, Ma, Dong, Zhu, Lingjun, Zhao, Qingchuan, Nie, Yongzhan, Cai, Xiaohong, Li, Qi, Fang, Weijia, Li, Hongyan, Wang, Ning, Chen, Yun, Peng, Cike, Fang, Honghao, Shen, Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7029588/ https://www.ncbi.nlm.nih.gov/pubmed/32070312 http://dx.doi.org/10.1186/s12885-020-6557-5

Ejemplares similares

HSP90-dependent PUS7 overexpression facilitates the metastasis of colorectal cancer cells by regulating LASP1 abundance
por: Song, Dan, et al.
Publicado: (2021)

Genetic variants in the Folic acid Metabolic Pathway Genes predict outcomes of metastatic Colorectal Cancer patients receiving first-line Chemotherapy
por: Jiang, Lu, et al.
Publicado: (2020)

Association of genetic variants in lncRNA H19 with risk of colorectal cancer in a Chinese population
por: Li, Shuwei, et al.
Publicado: (2016)

‘Druggable’ alterations detected by Ion Torrent in metastatic colorectal cancer patients
por: FANG, WEIJIA, et al.
Publicado: (2014)

The Real-World Practice of Fruquintinib for Chinese Patients with Metastatic Colorectal Cancer
por: Song, Yan, et al.
Publicado: (2021)

Multidrug-Resistance Related Long Non-Coding RNA Expression Profile Analysis of Gastric Cancer
por: Wang, Ying, et al.
Publicado: (2015)

D-Dimer level was associated with prognosis in metastatic colorectal cancer: A Chinese patients based cohort study
por: Liu, Chan, et al.
Publicado: (2020)

Efficacy and safety of chemotherapy combined with bevacizumab in Chinese patients with metastatic colorectal cancer: A prospective, multicenter, observational, non-interventional phase IV trial
por: Wang, Fenghua, et al.
Publicado: (2021)

Immunotherapy in colorectal cancer: current achievements and future perspective
por: Fan, Ahui, et al.
Publicado: (2021)

Interleukin‐33 as an early predictor of cetuximab treatment efficacy in patients with colorectal cancer
por: Zhang, Xujun, et al.
Publicado: (2021)

Role of capecitabine in treating metastatic colorectal cancer in Chinese patients
por: Wang, Feng, et al.
Publicado: (2014)

RNA-seq identifies differentially expressed genes involved in csal1 overexpression in granulosa cells of prehierarchical follicles in Chinese Dagu hens
por: Zhu, Hongyan, et al.
Publicado: (2022)

Clinicopathologic features and treatment efficacy of Chinese patients with BRAF-mutated metastatic colorectal cancer: a retrospective observational study
por: Wang, Xicheng, et al.
Publicado: (2017)

Association between calf circumference and incontinence in Chinese elderly
por: Li, Lin, et al.
Publicado: (2023)

Association study between XPG Asp1104His polymorphism and colorectal cancer risk in a Chinese population
por: Du, Haina, et al.
Publicado: (2014)

Regorafenib in Chinese patients with metastatic colorectal cancer: Subgroup analysis of the phase 3 CONCUR trial
por: Xu, Jianming, et al.
Publicado: (2020)

A Phase Ib Study of Pembrolizumab as Second-Line Therapy for Chinese Patients With Advanced or Metastatic Melanoma (KEYNOTE-151)()()()
por: Si, Lu, et al.
Publicado: (2019)

SMAD4 and NF1 mutations as potential biomarkers for poor prognosis to cetuximab-based therapy in Chinese metastatic colorectal cancer patients
por: Mei, Zhu, et al.
Publicado: (2018)

NDRG4 stratifies the prognostic value of body mass index in colorectal cancer
por: Zheng, Jianyong, et al.
Publicado: (2015)

Polymorphism rs2682818 in miR‐618 is associated with colorectal cancer susceptibility in a Han Chinese population
por: Chen, Yuetong, et al.
Publicado: (2018)

Efficacy of traditional Chinese exercise for the treatment of pain and disability on knee osteoarthritis patients: a systematic review and meta-analysis of randomized controlled trials
por: Zhang, Shuaipan, et al.
Publicado: (2023)

Genetic Variant rs7758229 in 6q26–q27 Is Not Associated with Colorectal Cancer Risk in a Chinese Population
por: Zhu, Lingjun, et al.
Publicado: (2013)

Mutation profiling in chinese patients with metastatic colorectal cancer and its correlation with clinicopathological features and anti-EGFR treatment response
por: Li, Zhe-Zhen, et al.
Publicado: (2016)

Healthcare at Your Fingertips: The Acceptance and Adoption of Mobile Medical Treatment Services among Chinese Users
por: Li, Qingchuan
Publicado: (2020)

Dysregulated microRNA expression profiles in gastric cancer cells with high peritoneal metastatic potential
por: Feng, Yaning, et al.
Publicado: (2018)

Development and validation of a prognostic nomogram for gastrointestinal stromal tumors in the postimatinib era: A study based on the SEER database and a Chinese cohort
por: Wang, Shu, et al.
Publicado: (2023)

Effect of Reduced-Dose Capecitabine Plus Cetuximab as Maintenance Therapy for RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Clinical Trial
por: Wang, Lu, et al.
Publicado: (2020)

Review on “Long-Dan”, one of the traditional Chinese medicinal herbs recorded in Chinese pharmacopoeia
por: Wang, Yan-Ming, et al.
Publicado: (2012)

Molecular targets of Chinese herbs: a clinical study of metastatic colorectal cancer based on network pharmacology
por: Zhu, Hongxu, et al.
Publicado: (2018)

Let food be thy medicine: the role of diet in colorectal cancer: a narrative review
por: Zheng, Ying, et al.
Publicado: (2022)

Phase II study of S‐1 plus leucovorin in patients with metastatic colorectal cancer: Regimen of 1 week on, 1 week off
por: Li, Jin, et al.
Publicado: (2017)

Integrated Chinese Herbal Medicine and Western Medicine on the Survival in Patients with Colorectal Cancer: A Retrospective Study of Medical Records
por: Yeh, Ming-Hsien, et al.
Publicado: (2020)

Phase II study of weekly irinotecan and capecitabine treatment in metastatic colorectal cancer patients
por: Li, Wenhua, et al.
Publicado: (2014)

Clonal Evolution Dynamics in Primary and Metastatic Lesions of Pancreatic Neuroendocrine Neoplasms
por: Tong, Zhou, et al.
Publicado: (2021)

Effect and safety of bevacizumab-containing chemotherapy treatment in Chinese patients with metastatic colorectal cancer
por: Wu, Qian, et al.
Publicado: (2013)

FBX8 promotes metastatic dormancy of colorectal cancer in liver
por: Zhu, Xiaohui, et al.
Publicado: (2020)

The molecular heterogeneity of sporadic colorectal cancer with different tumor sites in Chinese patients
por: Peng, Junjie, et al.
Publicado: (2017)

Association of emergence of new mutations in circulating tumuor DNA during chemotherapy with clinical outcome in metastatic colorectal cancer
por: Jia, Ning, et al.
Publicado: (2021)

H(2)SO(4) assisted hydrothermal conversion of biomass with solid acid catalysis to produce aviation fuel precursors
por: Zhu, Lingjun, et al.
Publicado: (2023)

Efficacy and safety of bevacizumab plus chemotherapy in Chinese patients with metastatic colorectal cancer: a randomized phase III ARTIST trial
por: Guan, Zhong-Zhen, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_n6r00ce3bklfs0pjp9v1vfkk7e